Published in Eur Respir J on July 01, 1993
Relation of the perception of airway obstruction to the severity of asthma. Thorax (1999) 1.14
Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate. Thorax (1996) 1.02
Dalhousie Dyspnea and perceived exertion scales: psychophysical properties in children and adolescents. Respir Physiol Neurobiol (2014) 0.83
Reported Exercise-Related Respiratory Symptoms and Exercise-Induced Bronchoconstriction in Asthmatic Children. J Clin Med Res (2017) 0.75
Pediatric Dyspnea Scale for use in hospitalized patients with asthma. J Allergy Clin Immunol (2009) 0.75
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35
Mapping of closed circular DNAs by cleavage with restriction endonucleases and calibration by agarose gel electrophoresis. Proc Natl Acad Sci U S A (1977) 7.09
The concept of disease. Br Med J (1979) 6.51
Restriction endonuclease cleavage maps of rat and mouse mitochondrial DNAs. Nucleic Acids Res (1977) 5.58
Effect of encouragement on walking test performance. Thorax (1984) 4.44
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
MAP kinase and cAMP filamentation signaling pathways converge on the unusually large promoter of the yeast FLO11 gene. EMBO J (1999) 3.89
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med (1998) 3.83
Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82
The J. Burns Amberson Lecture. The management of acute respiratory failure in chronic bronchitis and emphysema. Am Rev Respir Dis (1967) 3.35
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol (1999) 3.09
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet (1966) 2.94
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis (1992) 2.93
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med (1990) 2.80
Serial studies of 100 patients with chronic airway obstruction in London and Chicago. Thorax (1967) 2.77
Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis (1985) 2.73
How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61
The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol (1999) 2.58
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med (1999) 2.53
Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J Clin Invest (1991) 2.49
Difference between end-tidal and arterial PCO2 in exercise. J Appl Physiol Respir Environ Exerc Physiol (1979) 2.31
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20
The estimation of carbon dioxide pressure of mixed venous blood during exercise. Clin Sci (1967) 2.06
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment. J Cell Biol (1995) 2.02
The structures and fidelity of replication of mouse mitochondrial DNA-pSC 101 EcoRI recombinant plasmids grown in E. coli K12. Cell (1976) 2.02
Healing of spontaneous coronary dissection in the context of glycoprotein IIB/IIIA inhibitor therapy: a case report. Catheter Cardiovasc Interv (2000) 2.00
Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol (1995) 1.98
Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med (1995) 1.98
The diagnosing mind. Lancet (1987) 1.97
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol (2002) 1.92
Pulmonary gas exchange during exercise in patients with chronic airway obstruction. Clin Sci (1966) 1.91
Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest (1982) 1.90
A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis (1974) 1.87
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Characterization of the mannose/fucose receptor on human mononuclear phagocytes. J Reticuloendothel Soc (1982) 1.78
Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med (1987) 1.74
Reasons for dropout from exercise programs in post-coronary patients. Med Sci Sports Exerc (1981) 1.74
Legionella pneumophila in cooling water systems. Report of a survey of cooling towers in London and a pilot trial of selected biocides. J Hyg (Lond) (1982) 1.72
A novel mechanism of alternative RNA splicing for the developmentally regulated generation of troponin T isoforms from a single gene. Cell (1984) 1.71
Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med (1999) 1.69
Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J (2004) 1.68
Is nedocromil sodium effective treatment for asthma? Eur Respir J (1993) 1.67
Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy (2002) 1.66
Repeatability of physical signs in airways obstruction. Thorax (1969) 1.65
Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med (1998) 1.65
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol (1998) 1.62
Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest (1985) 1.61
Physical signs of diffuse airways obstruction and lung distension. Thorax (1969) 1.61
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
A method of distinguishing death due to cardiac arrest from asphyxia. Lancet (1967) 1.58
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Assessment of airway inflammation: an overview. Eur Respir J Suppl (1998) 1.55
OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy (2014) 1.54
Transcript quantitation in total yeast cellular RNA using kinetic PCR. Nucleic Acids Res (2000) 1.53
Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med (2000) 1.52
Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? Respir Med (2001) 1.52
Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis (1982) 1.51
Basic science, science, and medical education. Lancet (1976) 1.51
Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol (1999) 1.50
Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol (1985) (1985) 1.49
Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol (1997) 1.48
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax (2001) 1.48
Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro. J Clin Invest (1979) 1.46
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J (2009) 1.45
Calculation of whole blood CO2 content. J Appl Physiol (1985) (1988) 1.45
Cardiac output determination during progressive exercise in cystic fibrosis. Chest (1992) 1.44
Noncompliance in an exercise rehabilitation program for men who have suffered a myocardial infarction. Can Med Assoc J (1978) 1.43
Regulation of skeletal muscle glycogen phosphorylase and PDH during maximal intermittent exercise. Am J Physiol (1999) 1.41
Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med (1989) 1.41
Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J Clin Invest (1982) 1.41
Uptake and release of free fatty acids and other metabolites in the legs of exercising men. J Appl Physiol (1967) 1.41
Blood ion regulation during repeated maximal exercise and recovery in humans. Am J Physiol (1992) 1.40
Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax (1992) 1.39
The occlusal management of maxillary anterior single-unit implant-supported restorations. Dent Update (2000) 1.39
COPD: guidelines for all. Chronic obstructive pulmonary disease. Can Respir J (1999) 1.39
Pyruvate dehydrogenase activity and acetyl group accumulation during exercise after different diets. Am J Physiol (1993) 1.38